The impact of PET scanning on management of paediatric oncology patients

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 1, 2005, Pages 23-30

  Wegner, E A ^a   Barrington, S F ^a   Kingston, J E ^b   Robinson, R O ^c   Ferner, R E ^a   Taj, M ^d   Smith, M A ^a   O'Doherty, M J ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Brain neoplasms; Childhood cancer; Disease management; Lymphoma; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHIONINE C 11;

ADOLESCENT; CANCER DIAGNOSIS; CANCER PATIENT; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMA; POSITRON EMISSION TOMOGRAPHY; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SARCOMA;

ADOLESCENT; ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 12444304399     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1645-3     Document Type: Review

References (34)

1. Gambhir SS, Czernin J, Schwimmer J. Silverman DHS. Coleman E, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42:1S-93S.
2. Czernin J. Clinical applications of FDG-PET in oncology. Acta Med Austriaca 2002; 29:162-70.
3. Franzius C. Schober O. Assessment of therapy response by FDG PET in pediatric patients. Q J Nucl Med 2003; 47:41-5.
4. Shulkin BL. PET applications in pediatrics. Q J Nucl Med 1997; 41:281-91.
5. Plowman PN, Saunders CAB, Maisey M. On the usefulness of brain PET scanning to the paediatric neuro-oncologist. Br J Neurosurg 1997; 11:525-32.
6. Bruggers CS, Friedman HS, Fuller GN, et al. Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. Med Pediatr Oncol 1993; 21:301-6.
7. Hoffman JM, Hanson MW, Friedman HS, et al. FDG-PET in paediatric posterior fossa brain tumours. J Comput Assist Tomogr 1992; 16:62-8.
8. 11C]L-methionine PET in childhood brain tumours. Pediatr Neurol 1990; 6:163-70.
9. 18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 2000; 68:353-7.
10. Lucas JD, O'Doherty MJ, Wong JCH, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg (Br) 1998; 80:441-7.
11. Wilmshurst JM, Barrington SF, Pritchard D, et al. Positron emission tomography in imaging spinal cord tumours. J Child Neurol 2000; 15:465-72.
12. 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. J Nucl Med 2001; 42:586-90.
13. Gopalan D, Griffiths D, Townsend C, et al. Fluorodeoxyglucose positron emission tomography in clinical oncology: the referrer's perspective. Nucl Med Commun 2002; 23:1041-6.
14. Cook GJ, Maisey MN, Fogelman I. Normal variants, artefacts, and interpretive pitfalls in PET imaging with 18-fluoro-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 1999; 26:1363-78.
15. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 2002; 29:1393-8.
16. Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 1996; 37:1127-9.
17. 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med 2001; 42:591-5.
18. Boivin JF, Hutchinson GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995; 87:732-4.
19. Valagussa P, Santoro A, Bonadonna G. Thyroid, pulmonary and cardiac sequelae after treatment for Hodgkin's disease. Ann Oncol 1992; 3:111-5.
20. Schiepers C, Filmont J-E, Czernin J. PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med 2003; 30(Suppl 1):S82-8.
21. Reske SN. PET and restaging of malignant lymphoma including residual masses and relapse. Eur J Nucl Med Mol Imaging 2003; 30(Suppl 1):S89-96.
22. 18F]FDG for therapy response monitoring in lymphoma patients. Eur J Nucl Med Mol Imaging 2003; 30(Suppl 1):S97-105.
23. 18F]FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging 2002; 29:1155-65.
24. Chao ST, Suh JH, Raja S, Lee SY, Barnett G. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001;96:191-7.
25. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 1992; 185:581-6.
26. Hain SF, O'Doherty MJ, Bingham J, Chinyama C, Smith MA. Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours? Nucl Med Commun 2003; 24:1139-43.
27. Pirotte B, Goldman S, Salzberg S, et al. Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases. Pediatr Neurosurg 2003;38:146-55.
28. 11C-methionine positron emission tomography. Cancer 2002; 95:1376-86.
29. Holthoff VA, Herholz K, Berthold F, et al. In vivo metabolism of childhood posterior fossa tumours and primitive neuroectodermal tumours before and after treatment. Cancer 1993; 72:1394-403.
30. Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schrober O. Evaluation of chemotherapy response in primary bone tumours with F-18 FDG positron emission tomography compared with histologically assessed tumour necrosis. Clin Nucl Med 2000; 25:874-81.
31. Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001; 12:479-86.
32. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumours, a clinicopathologic study of 120 cases. Cancer 1986; 57:2006-21.
33. Borgwardt L, Larsen HJ, Pedersen K, Hojgaard L. Practical use and implementation of PET in children in a hospital PET centre. Eur J Nucl Med Mol Imaging 2003; 30:1389-97.
34. Stabin MG, Gelfand MJ. Dosimetry of pediatric nuclear medicine procedures. Q J Nucl Med 1998; 42:93-112.